Ismn Apogepha en es it fr

Ismn Apogepha Brand names, Ismn Apogepha Analogs

Ismn Apogepha Brand Names Mixture

  • No information avaliable

Ismn Apogepha Chemical_Formula

C6H9NO6

Ismn Apogepha RX_link

http://www.rxlist.com/cgi/generic/isomono2.htm

Ismn Apogepha fda sheet

http://www.fda.gov/cder/foi/anda/98/75-147_Isosorbide.htm

Ismn Apogepha msds (material safety sheet)

Ismn_Apogepha MSDS

Ismn Apogepha Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Ismn Apogepha Molecular Weight

191.139 g/mol

Ismn Apogepha Melting Point

88-91oC

Ismn Apogepha H2O Solubility

1.07E+005 mg/L

Ismn Apogepha State

Solid

Ismn Apogepha LogP

-0.15

Ismn Apogepha Dosage Forms

Tablet (immediate release); Tablet (extended release)

Ismn Apogepha Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Ismn Apogepha Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Ismn Apogepha Absorption

100%

Ismn Apogepha side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Ismn Apogepha Patient Information

Ismn Apogepha Organisms Affected

Humans and other mammals